Clinical epidemiology and risk factors of herpes zoster in Türkiye: a decade-long, multicenter retrospective cohort study
Open Access
- 9 February 2026
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Abstract
Herpes zoster (HZ) results from the reactivation of varicella-zoster virus (VZV) in dorsal root ganglia, often triggered by immune decline. This multicenteKeywords
This publication has 31 references indexed in Scilit:
- Klinik und Therapie des Herpes zoster und der postherpetischen NeuralgieDie Dermatologie, 2024
- The Incidence of Herpes Zoster Complications: A Systematic Literature ReviewInfectious Diseases and Therapy, 2024
- Efficacy and safety of brivudine for the treatment of herpes zoster: a systematic review and meta-analysisJournal of Dermatological Treatment, 2024
- Distinguishing community-acquired bacterial and viral meningitis: Microbes and biomarkersJournal of Infection, 2024
- Vaccines for preventing herpes zoster in older adultsCochrane Database of Systematic Reviews, 2023
- Hospitalization Burden Related to Herpes Zoster Infection in Spain (2016–2019)Infectious Diseases and Therapy, 2022
- Burden of Herpes Zoster in Adult Patients with Underlying Conditions: Analysis of German Claims Data, 2007–2018Dermatology and Therapy, 2021
- Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or OlderNew England Journal of Medicine, 2016
- Epidemiology and cost of herpes zoster and postherpetic neuralgia in GermanyThe European Journal of Health Economics, 2012
- Recent Advances in Reducing the Burden of Herpes Zoster and Postherpetic NeuralgiaThe Journal of Pain, 2008